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Abstract
Purpose: We aimed to determine the effect of intravenous thrombolytic therapy on QT dispersion (QTd) and its role in 
the prediction of reperfusion arrhythmias.
Materials and Methods: Twenty patients with acute myocardial infarction (MI) were enrolled in the study. Measurements 
of QTd were carried out prior to thrombolytic therapy and before discharge. The patients were examined for ventricular 
arrhythmias with 24‑h Holter electrocardiography monitoring after treatment and the relationship between ventricular 
arrhythmias and the QTd values in the early phase of MI was investigated.
Results: The values of QTd were significantly higher during the early phase of MI (60 ± 5.32 ms) than those in the late 
phase (53.35 ± 4.07 ms) (P = 0.032).
There was no correlation between isolated, bigeminal, trigeminal and total ventricular premature beats, accelerated 
idioventricular rhythm (AIVR) with QTd values. However, the patients with sustained ventricular tachycardia (VT), 
prolonged VT and sustained AIVR had higher corrected QTd (92 ms1/2, 97.8 ms1/2, 81.7 ms1/2, respectively) than the 
patients without these arrhythmias (74 ms1/2, 56.3 ms1/2, 58.28 ms1/2, respectively) (P = 0.022, 0.013, 0.018).
Conclusion: The values of QTd may be significantly reduced in the 1st week of acute MI and measurement of QTd in the 
early phase of MI may have a correlation with the following reperfusion arrhythmias: Sustained VT, prolonged VT and AIVR.
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Introduction
The variation in QT interval between surface 
electrocardiography (ECG) leads has been considered to be 
valuable clinical data reflecting heterogeneity of ventricular 
recovery.[1] QT dispersion (QTd) is defined as the difference 
between maximum and minimum QT intervals measured by 
12‑lead ECG and is considered a predictor of arrhythmia risk.[1]
Early thrombolytic therapy in cases with acute myocardial 
infarction (MI) results in reduced early and late mortality 
along with preservation of myocardial function.[2‑4] However, 
reperfusion with lytic therapy may have an effect on 
electrical stability and results in reperfusion arrhythmias.[5,6] 
Mortality associated with arrhythmias in the acute phase of 
MI is still high and restoration of blood flow by thrombolysis 
can paradoxically elevate this risk further.[7] Regarding 
the safe administration of thrombolytic therapy, the 
risk for arrhythmias should be determined more clearly. 
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Measurement of QTd prior to reperfusion may predict the 
frequency and severity of the reperfusion arrhythmias.
In the present study, we aimed to determine the effect of 
intravenous thrombolytic therapy on QTd and its role in 
the prediction of reperfusion arrhythmias within the 1st 24 h 
among MI patients.
Materials and Methods
This study was a prospective, cross‑sectional study and 
20 patients diagnosed with acute MI were enrolled in the 
study. Acute MI diagnosis was established in the presence of 
typical rise and/or fall of creatine kinase levels with typical 
chest pain lasting for >30 min or ECG changes consistent 
with an acute MI (ST segment height >0.1 mV in at least 
two frontal leads or >0.2 mV in at least two precordial 
leads). Of the patients, 12 had anterior MIs and eight had 
inferior MIs.
Patients, who presented within the 1st 6 h (mean, 3.4 h) 
after the onset of chest pain, and who were eligible for 
thrombolytic therapy, were treated with an intravenous 
streptokinase infusion of 1.5 million unit/h. All of the 
patients had ST segment resolution of more than 50% at 
90 min of treatment and had resolution of chest pain as 
indicators of successful reperfusion. Just after streptokinase 
infusion, by placing the bipolar electrodes corresponding to 
a modified V5 and a ventricular fibrillation (VF) position, 
24‑h Holter ECG monitoring was performed on 1 day 
post‑thrombolysis. Holter records were carried out using 
an Oxford® Medilog FD2 two‑channel recorder. The 
records were transferred to a computer and automatic 
arrhythmia analysis was performed using Medilog® Prima 
Analysis System, and verified by full disclosure 24‑h 
recording. The values of isolated and total ventricular 
premature beats (VPBs), as well as frequency of the 
accelerated idioventricular rhythm (AIVR) ≥3 consecutive 
VPBs < 100 beats/min), ventricular tachycardia (VT) ≥3 
monomorphic or polymorphic consecutive VPBs > 100 
beats/min), sustained VT (VT lasting > 30 s), sustained 
AIVR (lasting ≥ 32 beats), and prolonged VT (lasting ≥ 15 
beats) were determined.
In all the patients, the ECGs obtained prior to thrombolytic 
therapy (early phase) and in the late phase before discharge (at 
mean 6.7 days of infarction) were analyzed. QT interval 
analysis was performed manually by surface ECGs at 25 mm/s 
rate and 10 mV amplitude. Patients with a significant 
intraventricular conduction defect or atrial fibrillation were 
excluded from the study. Each ECG with at least seven leads 
being technically capable of measuring was included in the 
study. For each lead, the mean QT interval and corrected 
QT (QTc) values were measured. QT measurements were 
carried out according to the standard criteria.[8] In the 
presence of a U wave, the intersection point of T and U waves 
was determined as the end of the QT interval. Correction 
of the QT interval with respect to heart rate was performed 
with Bazett’s formula.[9] According to this formula, QTc 
was measured by dividing the QT interval (in seconds) 
by the square root of the RR interval value (in seconds). 
QTd was defined as the difference between maximum and 
minimum QT intervals measured by 12‑lead ECG (8) and 
QTc dispersion (QTcd) was defined as the difference between 
the maximum and minimum QTc. The corrected QTcd value 
was obtained by dividing the QTcd by the square root of the 
number of leads, which is a measure that includes for between 
accounts the number of leads. There is no universal definition 
of abnormal QTd and QTcd limits.
Informed consent was obtained from all patients. The 
study was approved by our local ethical committee. All 
demographic and clinical data were collected.
Statistical analysis
All data were analyzed with Statistical Package for the 
Social Sciences (SPSS) 13.0 software (SPSS Inc., Chicago, 
IL, USA). The Wilcoxon test was used to analyze whether 
the values in two samples differ in size while continuous 
variables were analyzed with Mann‑Whitney U test. The 
relationship between the QTd and other parameters 
were determined by simple linear regression analysis. The 
results were presented as the mean ± standard deviation. 
A P < 0.05 was considered as statistically significant.
Results
The mean age of the patients was 51.75 ± 2.8 years (range, 
30‑73 years). The clinical characteristics of the patients are 
presented in Table 1.
For assessing the reproducibility (verification of the accuracy) 
of QTcd measurements, different QTcd measurements were 
performed randomly on 52 leads by two different raters. An 
insignificant average difference of 5 ms1/2 was determined 
between the measurements of the two raters.
QTd and QTcd values measured in the early MI phase 
Table 1: Clinical characteristics of the patients
Clinical characteistics Patients (n=20)
Mean age (±SD), years 51.75±2.8
Female, n (%) 1 (5)
Male, n (%) 19 (95)
MI history (+), n (%) 3 (15)
Hypertension, n (%) 5 (25)
Diabetes, n (%) 1 (5)
Smoking, n (%) 14 (70)
Anterior MI, n (%) 12 (60)
Inferior MI, n (%) 8 (40)
MI=Myocardial infarction; SD=Standard deviation
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according to the location of infarction are outlined in 
Table 2. There was no significant difference between the 
QTd values of patients with inferior and anterior MI.
QTd, QTcd, corrected QTcd, and maximum and minimum 
values of QT and QTc intervals before and after the 
thrombolytic therapy are shown in Table 3. The values of 
QTd (ms), QTcd (ms
1/2) and corrected QTcd (ms) of the 
patients were significantly higher during the early phase 
of MI than those in the late phase of MI. The decreases in 
the values of QTmax and QTcmax after the thrombolytic 
therapy led to these differences.
During the hospitalization period, four patients (25%) 
developed clinical heart failure, one patient (5%) died, and 
one patient (5%) developed VF. The values of QTcd and 
corrected QTcd in patients who did and did not develop 
complications is presented in Table 4. Although the number 
of patients was not sufficient to make statistical comparisons, 
dispersion values of the patients who died or developed VF 
were considerably higher than the overall average values. 
There was no significant difference between the values 
of QTcd and corrected QTcd in patients with and without 
heart failure. Simple linear regression analysis revealed no 
correlation between the ejection fraction and peak creatine 
kinase levels, and QTcd values in the late phase of MI in 
all patients.
Reperfusion arrhythmias
Ventricular arrhythmias after thrombolytic therapies were 
analyzed by a 24‑h Holter ECG. VPBs were observed in all 
patients. The mean number of isolated VPBs in 24 h was 
1189 ± 273. In the analysis of ventricular arrhythmias, bigeminal 
or trigeminal VPBs were observed in 15 patients (75%), both 
bigeminal and trigeminal VPBs in eight patients (40%), and 
AIVR episodes in 18 patients (90%). No correlation was 
found between QTc and arrhythmia parameters. There was 
no correlation between QTd and the mean isolated and 
total VPBs in the linear regression analysis. Seventeen (85%) 
patients had non‑sustained VT. There was no difference 
between patients with and without non‑sustained VT in terms 
of QTcd values. One (5%) patient had sustained VT with a 
QTcd value of 92 ms
1/2. The mean QTcd value for all patients 
was 74.2 ± 7.2 ms1/2 (92 ms1/2, 74.2 ± 7.2 ms1/2, respectively 
P = 0.032). Six (30%) patients with prolonged VT had higher 
QTcd than those without prolonged VT (97.8 ± 8.6 ms
1/2, 
56.3 ± 5.4 ms1/2, respectively P = 0.012). Sustained AIVR 
was determined in eight patients (40%), and QTcd values were 
higher in those patients as well (81.7 ± 7.6 ms1/2, 58.28 ± 6.4 
ms1/2, respectively P = 0.029) [Figure 1]. Linear regression 
analysis revealed a correlation between the QTcd values and 
the number of episodes of arrhythmias exhibited by patients 
with the above‑mentioned 3 types of arrhythmias.
Discussion
In acute MI, early fibrinolytic therapy is known to reduce 
mortality. Improvement in the left ventricular functions 
and reduction of late arrhythmias by enhancing electrical 
stability of the heart may decrease the rate of sudden 
deaths.[2‑4] Thus, thrombolytic therapy is expected to have 
a positive effect on late arrhythmic events after infarction. 
Indeed, thrombolytic therapy have been reported to reduce 
late potential frequency and decrease VT frequency, which 
was induced spontaneously or by programmed simulation 
in various studies.[10,11]
It has been found that the QT interval dispersion in 
patients with MI was higher than those without heart 
Table 2: QT dispersion values according to the 









QTd (ms) 64.81±6.85 57.04±4.14 0.23
QT
c
d (ms1/2) 82.56±9.9 70.33±6.11 0.18
MI=Myocardial infarction; QTd=QT dispersion; QTcd=QTc dispersion. 
P<0.05 was considered as statistically significant
Table 4: QT dispersion values of the patients who did or did not develop complications during hospitalization period
QT cd values Heart failure Death Ventricular fibrillation
(+) (−) (+) (−) (+) (−)
QT
c
d (ms1/2) 77.8±8.1 75.4±9.4 94.6±6.5 74.7±5.5 89.2±7.4 73.9±8.4
Corrected QT
c
d (ms) 24.2±3.1 23.5±4.4 36.5±6.4 23.2±3.7 34.6±3.6 23.5±4.2
QTcd=QTc dispersion
Table 3: Values of QT and QT
c
 dispersion, corrected QT
c
 
dispersion and maximum and minimum QT and QT
c
 
intervals measured during the early and late phase of 
myocardial infarction in the study group
Values Early phase Late phase P
QT max. (ms) 441.65±9.73 404.04±8.48 0.018
QT
c
 max. (ms1/2) 474.35±9.69 377.37±9.27 0.011
QT min. (ms) 381.65±7.15 377.37±9.27 0.32
QT
c
 min. (ms1/2) 401.95±6.74 395.37±6.35 0.15
QTd (ms) 60±5.32 53.35±4.07 0.032
QT
c
d (ms1/2) 75.75±8.21 65.35±5.07 0.013
Corrected QT
c
d (ms) 23±3.4 20.9±3.2 0.044
Max=Maximum; Min=Minimum; QTd=QT dispersion; 
QTcd=QTc dispersion. P<0.05 was considered as statistically significant
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disease.[12,13] Studies focusing on the relationship of QTd 
and late arrhyhmias in patients with MI have contradictory 
results.[14‑17] The current study suggested that thrombolysis 
could cause a significant decrease in the QTd value during 
the subsequent late phase of MI although any form of 
reperfusion including natural course and percutaneous 
coronary intervention could have resulted in this effect. 
Studies have reported contradictory results regarding 
the timing of QTd measurement in acute MI and the 
association between arrhythmias and QTd values.[18‑23] 
Our study fell short of shedding light on those contentious 
issues as well.
In the present study, in order to identify the effect of 
infarction localization on QTd, QTcd was measured 
separately in anterior and inferior MIs. Although QTcd 
was higher in the anterior MI, the difference was not 
statistically significant. Several studies have demonstrated 
conflicting results on this subject.[13,17] In the study of 
Cowan et al. the mean QTd value was 70 ms in the anterior 
MI and 73 ms in the inferior MI while it was 48 ms in 
patients without MI.[13] In consistent with these findings, 
the mean QTd value of patients with MI was 74 ms in the 
present study.
While the studies have demonstrated a correlation between 
QTd and ejection fraction in clinical conditions other than 
MI, such as congestive heart failure and idiopathic dilated 
cardiomyopathy,[24] no evidence of such a correlation among 
MI patients has been reported.[25] In the present study, 
no difference was determined between patients with and 
without clinical heart failure in terms of the QTd values, 
and no correlation was obtained between the QTd values 
and ejection fraction, as well.
Reperfusion arrhythmias
In various studies, arrhythmias occurring during coronary 
perfusion have been analyzed. Those arrhythmias increase 
mortality risk. In addition to the arrhythmias observed in the 
acute phase of infarction, reopening of the infarct‑related 
artery may increase the risk of arrhythmia even further and 
serious arrhythmias may appear.[26‑30]
In large series studies focusing on thrombolytic therapy 
in acute MI, in particular VF arrhythmias have been 
investigated.[2,3] This is an uncommon arrhythmia with a 
frequency of 3.7‑6.6%. Following MI, VF has been shown to 
have a frequency of 2.3‑5.3% in day 1 and 2.5‑15% within 
the first 2 weeks.[2,3,28,30] In our study, none of the patients 
demonstrated VF within the 1st day; only one patient (5%) 
demonstrated VF within the 1st week after MI. In those 
studies, VT and AIVR frequencies have not been taken 
into consideration due to the technical difficulties in their 
detection and their benign characteristics. In some series 
including the use of Holter ECG monitoring, the VT 
frequency was 80% and AIVR frequency was 87.5%.[29,30] In 
the current study, we found non‑sustained VT in 17 (85%) 
patients and AIVR in 18 (90%) patients.
The prognostic importance of early arrhythmias in the 
acute phase of an acute MI is not known well. Generally, 
frequent and/or complex arrhythmias are regarded as 
independent markers of prognosis after MI.[29] In cases 
presenting as ischemia and left ventricular dysfunction, 
the risk is elevated. Studies using ECG Holter monitoring 
have demonstrated a relationship between high‑risk 
ventricular arrhythmias, and sudden death and total 
cardiac death.[28,29] Several studies have reported 
controversial results regarding the likelihood of ventricular 
arrhythmias (such as AIVR) being an indicator of 
reperfusion and being a predictor of prognosis during the 
thrombolytic therapy.[29,30]
While there are many studies in the literature investigating 
the associations between QTd and arrhythmias of various 
clinical conditions,[1,24] the objective of this study was focusing 
on the relationship between the reperfusion arrhythmias and 
QTd particularly. In the current study, we investigated the 
correlation between the early period QTd and ventricular 
arrhythmias occurring after the thrombolytic therapy using 
the 24‑h Holter ECG monitoring. Although there was no 
correlation between the isolated and the total number of 
VPBs and QTd, QTd values were higher in patients with 
serious ventricular arrhythmias, such as sustained VT, 
prolonged VT, and sustained AIVR. Thus, QTd may be 
suggested as a predictor of some reperfusion arrhythmias.
QTd is not the only predictor of arrhythmogenesis. In 
determining the incidence of arrhythmias, measurement 
of QTd in combination with the autonomic markers such 
as heart rate variability, T wave alternans and baroreflex 
sensitivity may prove to be useful in the early prediction 
of serious ventricular arrhythmias. By using these 
methods, problems and costs associated with invasive 
electrophysiological studies can be avoided.
Figure 1: QTc dispersion values in patients with ventricular 
arrhythmias. VT: Ventricular tachycardia; AIVR: Accelerated 
idioventricular rhythm
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In conclusion, an elevated QTcd value can act like a marker 
for early prediction of reperfusion arrhythmias occurring 
in the acute phase of MI, such as sustained VT, prolonged 
VT and sustained AIVR. However, the importance of 
QTd in the prediction of arrhythmia risk is still unclear. 
By standardizing the method of QTd measurements and 
maintaining the availability of computerized systems that 
can allow practical use in many cases, the actual role of QTd 
in reperfusion arrhythmias may become clear.
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